Book Online or Call 1-855-SAUSALITO

Sign In  |  Register  |  About Sausalito  |  Contact Us

Sausalito, CA
September 01, 2020 1:41pm
7-Day Forecast | Traffic

  • Search Hotels in Sausalito

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Biocryst Pharma Inc (NQ: BCRX )

6.150 +0.270 (+4.59%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 1, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 4,408,161
Open 5.930
Bid (Size) 6.160 (1)
Ask (Size) 6.190 (7)
Prev. Close 5.880
Today's Range 5.725 - 6.170
52wk Range 4.825 - 12.93
Shares Outstanding 185,583,896
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Where BioCryst Pharma Stands With Analysts
Via Benzinga
BioCryst Pharmaceuticals (BCRX) Q3 2023 Earnings Call Transcript
BCRX earnings call for the period ending September 30, 2023. 
Via The Motley Fool
Topics Earnings
Exposures Financial

Performance

YTD
-46.29%
-46.29%
1 Month
+9.04%
+9.04%
3 Month
-12.77%
-12.77%
6 Month
-22.93%
-22.93%
1 Year
-51.92%
-51.92%

More News

Read More
What 7 Analyst Ratings Have To Say About BioCryst Pharma
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 18, 2023
Via Benzinga
Analyst Expectations for BioCryst Pharma's Future
Via Benzinga
Why BioCryst Pharmaceuticals Stock Is Soaring Today
Via The Motley Fool
BioCryst Clocks 37.8% Revenue Growth In Q1 On Solid New Patient Growth
Via Benzinga
3 Magnificent Growth Stocks to Buy on the Dip
Via The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For August 4, 2023
Via Benzinga
BioCryst Pharmaceuticals (BCRX) Q2 2023 Earnings Call Transcript
Via The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For July 13, 2023
Via Benzinga
Recap: BioCryst Pharma Q1 Earnings
Via Benzinga
BioCryst Pharmaceuticals (BCRX) Q1 2023 Earnings Call Transcript
Via The Motley Fool
Why Is BioCryst Pharmaceuticals (BCRX) Stock Down 8% Today?
Via InvestorPlace
Ericsson, Johnson & Johnson, Goldman Sachs And Other Big Stocks Moving Lower On Tuesday
Via Benzinga
Why Shares of BioCryst Pharmaceuticals Jumped Today
Via The Motley Fool
Analyst Sees Attractive Entry Opportunity After BioCryst's Pipeline Setback
Via Benzinga
Why BioCryst Pharmaceuticals Stock Is Sinking Today
Via The Motley Fool
Biocryst Pharmaceuticals's Earnings Outlook
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 22, 2023
Via Benzinga
Why CVRx Shares Are Trading Lower By 43%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
BioCryst Pharmaceuticals (BCRX) Q4 2022 Earnings Call Transcript
Via The Motley Fool
Why BioCryst Pharmaceuticals Stock Is Sliding Today
Via Benzinga
Why Cutera Shares Are Trading Lower By 23%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
BioCryst Pharmaceuticals Stock Is Tumbling: What's Going On?
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Photos copyright by Jay Graham Photographer
Copyright © 2010-2020 Sausalito.com & California Media Partners, LLC. All rights reserved.